Market News (Page 9) - TendieTensor

Market News Page 9 of 158 • 3,936 articles

רוזן, משרד עורכי דין מוביל, מעודד את משקיעי Stride, Inc לקבל ייעוץ משפטי לפני המועד החשוב בתביעה ייצוגית בניירות ערך – LRN

GlobeNewswire Inc. • Rosen Law Firm

רוזן, משרד עורכי דין מוביל, מעודד את משקיעי Stride, Inc לקבל ייעוץ משפטי לפני המועד החשוב בתביעה ייצוגית בניירות ערך – LRN

11/27/2025 11:48 AM • Rosen Law Firm alerts Stride, Inc. investors about an upcoming class action lawsuit deadline on January 12, 2026, related to alleged misleading statements about the company's educational products and services.

NEWTP - Company is expanding leadership, focusing on innovative financial solutions for small businesses, and positioning itself to redefine payment processing with advanced technology
LRN - The lawsuit alleges the company inflated enrollment numbers, cut staff costs beyond legal limits, ignored compliance requirements, and lost existing and potential registrations, which suggests significant operational and ethical issues

#securities lawsuit #class action #investor rights #financial disclosure

ROSEN, A LEADING LAW FIRM, Encourages Stride, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LRN

GlobeNewswire Inc. • Rosen Law Firm

ROSEN, A LEADING LAW FIRM, Encourages Stride, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LRN

11/27/2025 11:48 AM • Rosen Law Firm is notifying Stride, Inc. investors of a securities class action lawsuit alleging misleading statements about enrollment numbers, staff costs, and compliance during the period of October 22, 2024 to October 28, 2025.

NEWTI - Company is expanding leadership, focusing on innovative financial solutions for small businesses, and positioning itself to redefine payment processing with advanced technology
LRN - The lawsuit alleges the company inflated enrollment numbers, cut staff costs beyond statutory limits, ignored compliance requirements, and lost existing and potential enrollments, suggesting significant operational and ethical issues

#securities #class action #lawsuit #investor rights #misleading statements

ROSEN, A LEADING LAW FIRM, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE

GlobeNewswire Inc. • Rosen Law Firm

ROSEN, A LEADING LAW FIRM, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE

11/27/2025 11:46 AM • Rosen Law Firm notifies Skye Bioscience investors of a securities class action lawsuit alleging false statements about the company's drug nimacimab and its clinical prospects, with a lead plaintiff deadline of January 16, 2026.

BAC - Mentioned as previous employer of new executive, with no direct commentary about the bank's performance
SKYE - The lawsuit alleges the company made materially false and misleading statements about nimacimab's effectiveness, clinical prospects, and overall business operations, suggesting potential misconduct and investor harm

#securities class action #nimacimab #investor rights #misleading statements

רוזן, משרד עורכי דין מוביל, מעודד את משקיעי Skye Bioscience, Inc לקבל ייעוץ משפטי לפני מועד מועד חשוב בתביעה ייצוגית בניירות ערך – SKYE

GlobeNewswire Inc. • Rosen Law Firm

רוזן, משרד עורכי דין מוביל, מעודד את משקיעי Skye Bioscience, Inc לקבל ייעוץ משפטי לפני מועד מועד חשוב בתביעה ייצוגית בניירות ערך – SKYE

11/27/2025 11:46 AM • Rosen Law Firm notifies Skye Bioscience investors of an upcoming class action lawsuit deadline on January 16, 2026, related to allegedly misleading statements about the company's clinical drug nimacimab and its potential effectiveness.

NEWTZ - Company is expanding leadership, focusing on innovative financial solutions for small businesses, and positioning itself to redefine payment processing with advanced technology
SKYE - The lawsuit alleges that the company made false and materially misleading statements about its business, operations, and future prospects, specifically regarding the clinical effectiveness of its drug nimacimab, which suggests potential corporate misconduct and investor deception

#securities lawsuit #class action #investor rights #nimacimab #misleading statements

Succès du douzième plan d’actionnariat salarié de Capgemini

GlobeNewswire Inc. • Victoire Grux

Succès du douzième plan d’actionnariat salarié de Capgemini

11/27/2025 11:45 AM • Capgemini successfully launched its twelfth Employee Share Ownership Plan (ESOP), surpassing 100,000 active participants across 36 countries. The capital increase represents 1.6% of the group's share capital and will maintain employee shareholding around 8%.

BACpE - Mentioned as previous employer of new executive, with no direct commentary about the bank's performance
CGEMY - The company achieved record participation in its employee share ownership plan, demonstrating strong employee engagement and confidence in the company's strategy

#ESOP #employee shareholding #capital increase #employee ownership

Ipsos: Monthly declaration of shares and voting rights - October 2025

GlobeNewswire Inc. • Ipsos

Ipsos: Monthly declaration of shares and voting rights - October 2025

11/27/2025 11:45 AM • Ipsos released its monthly disclosure of total shares and voting rights for October 31, 2025, reporting 43,203,225 shares and 48,977,829 theoretical voting rights.

BACpB - Mentioned as previous employer of new executive, with no direct commentary about the bank's performance
IPSAY - The document is a routine financial disclosure providing standard information about share and voting rights, with no explicit positive or negative indicators

#shares #voting rights #financial disclosure #market research

U.S. CAR T-Cell Therapies Market Grows at 30.4% CAGR, Soars USD 42.61 Billion by 2035

GlobeNewswire Inc. • Towards Healthcare

U.S. CAR T-Cell Therapies Market Grows at 30.4% CAGR, Soars USD 42.61 Billion by 2035

11/27/2025 11:00 AM • The U.S. CAR T-cell therapies market is expected to grow from USD 3.43 billion in 2026 to USD 42.61 billion by 2035, driven by rising cancer cases, research investments, and innovative therapeutic approaches.

JNJ - Listed as a key market player in CAR T-cell therapies with potential for significant market expansion

#CAR T-cell #immunotherapy #cancer treatment #cell therapy #market growth

SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • The Schall Law Firm

SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit with the Schall Law Firm

11/27/2025 11:00 AM • The Schall Law Firm is pursuing a class action lawsuit against Synopsys for alleged securities fraud, claiming the company made false and misleading statements about its AI customer focus and Design IP business between December 2024 and September 2025.

OXY.WS - Company is declaring a consistent dividend, indicating financial stability and commitment to shareholder value
SNPS - The lawsuit alleges the company made false statements that negatively impacted investors, with claims that their strategic decisions around AI customers were unlikely to yield intended results, causing investor damages

#securities fraud #class action lawsuit #AI customers #Design IP

Tuck End Box Market Size, Trends, Regional Share and Competitive Analysis

GlobeNewswire Inc. • Towards Packaging

Tuck End Box Market Size, Trends, Regional Share and Competitive Analysis

11/27/2025 11:00 AM • The global tuck end box market is projected to expand significantly through 2034, driven by rising e-commerce, increasing demand in food, beverage, cosmetic, and pharmaceutical sectors, and a growing preference for sustainable, customizable packaging solutions.

SW - Manufactures eco-friendly corrugated and folding carton packaging with specific tuck-end designs

#packaging #tuck end boxes #e-commerce #sustainability #market growth

$21.5+ Bn Travel Retail Tobacco Global Market Opportunities and Strategies to 2034: Opportunities in a Rise in Duty-free Zones, Business Travel, and Cruise Tourism

GlobeNewswire Inc. • Researchandmarkets.Com

$21.5+ Bn Travel Retail Tobacco Global Market Opportunities and Strategies to 2034: Opportunities in a Rise in Duty-free Zones, Business Travel, and Cruise Tourism

11/27/2025 10:59 AM • The global travel retail tobacco market is projected to grow from $8.04 billion in 2024 to $21.53 billion by 2034, with Asia Pacific and North America leading growth. Next-generation products and airport sales are expected to be the fastest-growing segments.

DUFRY - Largest market competitor with 24.02% market share, indicating strong market position

#travel retail #tobacco #duty-free #market growth #next-generation products

$230+ Bn K-12 Education Technology Global Market Opportunities and Strategies to 2034

GlobeNewswire Inc. • Researchandmarkets.Com

$230+ Bn K-12 Education Technology Global Market Opportunities and Strategies to 2034

11/27/2025 10:55 AM • The global K-12 education technology market is projected to grow from $25.6 billion in 2024 to $230.18 billion by 2034, driven by personalized learning, AI integration, and gamified educational platforms, with fastest growth expected in Asia Pacific and Africa.

NEWTG - Company is expanding leadership, focusing on innovative financial solutions for small businesses, and positioning itself to redefine payment processing with advanced technology
MSFT - Positioned in emerging education technology market with 1.27% market share

#education technology #AI learning #personalized education #edtech #online learning

Artificial Intelligence (AI) Pathology Quality Control Market Report 2025: Market to Reach $3.84 Billion by 2029, Driven by Rising Cancer Burden, Diagnostic Accuracy Demand, and Personalized Medicine

GlobeNewswire Inc. • Researchandmarkets.Com

Artificial Intelligence (AI) Pathology Quality Control Market Report 2025: Market to Reach $3.84 Billion by 2029, Driven by Rising Cancer Burden, Diagnostic Accuracy Demand, and Personalized Medicine

11/27/2025 10:53 AM • The AI pathology quality control market is projected to grow from $1.46 billion in 2024 to $3.84 billion by 2029, driven by rising cancer prevalence, demand for diagnostic accuracy, and personalized medicine advancements.

NEWTH - Company is expanding leadership, focusing on innovative financial solutions for small businesses, and positioning itself to redefine payment processing with advanced technology
RHHBY - Mentioned as a key market player with potential for growth in AI pathology quality control

#AI pathology #healthcare technology #personalized medicine #diagnostic accuracy #market growth

Rice Paper Packaging Market Size, Trends, Value Chain & Trade Analysis 2025-2035

GlobeNewswire Inc. • Towards Packaging

Rice Paper Packaging Market Size, Trends, Value Chain & Trade Analysis 2025-2035

11/27/2025 10:00 AM • The global rice paper packaging market is projected to expand from $177.29 billion in 2026 to $324.58 billion by 2034, driven by increasing demand for sustainable, biodegradable packaging solutions across food, cosmetics, and retail industries.

SPPJY - Developing recycled mono-material high-barrier papers that provide excellent protection while remaining recyclable

#rice paper packaging #sustainable packaging #biodegradable materials #eco-friendly packaging #plastic alternatives

Squawka releases Moneyball Index: ranking how well Premier League clubs convert transfer spending into on-pitch results

GlobeNewswire Inc. • Tom Dutton

Squawka releases Moneyball Index: ranking how well Premier League clubs convert transfer spending into on-pitch results

11/27/2025 10:00 AM • Squawka's Moneyball Index evaluates Premier League clubs' transfer spending efficiency over five seasons, revealing Brighton as the most efficient, while Manchester United ranks among the least efficient spenders.

NVDA - Recently became first company to cross $5 trillion market cap, indicating strong market performance
MANU - Ranked as one of the league's least efficient spenders, underperforming relative to transfer investments

#transfer spending #Premier League #performance efficiency #football analytics

MRX Investors Have Opportunity to Lead Marex Group plc Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • The Schall Law Firm

MRX Investors Have Opportunity to Lead Marex Group plc Securities Fraud Lawsuit with the Schall Law Firm

11/27/2025 10:00 AM • The Schall Law Firm is notifying Marex Group plc investors about a potential securities fraud class action lawsuit, alleging false financial statements and misleading market communications between May 16, 2024 and August 5, 2025.

MRX - The lawsuit alleges the company made false and misleading statements, sold over-the-counter financial products to itself, had inconsistent financial statements, and caused investor damages

#securities fraud #class action lawsuit #financial misconduct #investor rights

GSMA brings M360 Eurasia 2026 to Samarkand in partnership with VEON’s Beeline Uzbekistan and Uzbekistan’s Ministry of Digital Technologies

GlobeNewswire Inc. • Veon Ltd.

GSMA brings M360 Eurasia 2026 to Samarkand in partnership with VEON’s Beeline Uzbekistan and Uzbekistan’s Ministry of Digital Technologies

11/27/2025 10:00 AM • GSMA will host M360 Eurasia 2026 in Samarkand, Uzbekistan, in partnership with Beeline Uzbekistan and the Ministry of Digital Technologies, highlighting the country's digital transformation strategy and regional connectivity potential.

VEON - Company is actively expanding its digital presence and playing a key role in organizing a significant regional technology conference

#digital transformation #mobile industry #Eurasia #technology conference #Uzbekistan

Human Growth Hormone Injection Market Size Expected to Reach USD 8.54 Bn by 2035

GlobeNewswire Inc. • Towards Healthcare

Human Growth Hormone Injection Market Size Expected to Reach USD 8.54 Bn by 2035

11/27/2025 10:00 AM • The human growth hormone injection market is expected to grow at a 6.55% CAGR, reaching $8.54 billion by 2035. North America currently dominates the market, with branded HGH injections leading in revenue. Key growth drivers include increased diagnosis of growth disorders and expanding therapeutic applications.

PFE - Announced advancements in long-acting growth hormone candidate Somatropin-LA with promising Phase 3 results, indicating strong research and development capabilities

#human growth hormone #HGH #medical market #biotechnology #endocrinology

Processed Meat Market Size to Worth USD 1,265.70 Billion by 2034 | Towards FnB

GlobeNewswire Inc. • Towards Fnb

Processed Meat Market Size to Worth USD 1,265.70 Billion by 2034 | Towards FnB

11/27/2025 10:00 AM • The global processed meat market is projected to grow from $740.95 billion in 2025 to $1,265.70 billion by 2034, with a CAGR of 6.13%. Key growth drivers include convenience, technological innovations, and changing consumer preferences across regions like Asia Pacific and Middle East & Africa.

HRL - Leading producer with diverse processed meat portfolio and strong retail brands

#processed meat #market growth #food technology #convenience foods #protein products

Hepatic Encephalopathy Market Analysis and Forecast, 2025-2035 - Key Players Shape the Market with Strategic Partnerships and Innovative Therapies

GlobeNewswire Inc. • Researchandmarkets.Com

Hepatic Encephalopathy Market Analysis and Forecast, 2025-2035 - Key Players Shape the Market with Strategic Partnerships and Innovative Therapies

11/27/2025 09:59 AM • Global hepatic encephalopathy market expected to grow steadily, driven by rising liver disease prevalence, improved diagnostics, and novel therapies, despite challenges like high treatment costs and underdiagnosis.

CPIX - Mentioned as a key player in the market without specific positive or negative context

#hepatic encephalopathy #liver disease #medical market #therapeutic innovations #healthcare

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Alexandria Real Estate Equities, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ARE

GlobeNewswire Inc. • Rosen Law Firm

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Alexandria Real Estate Equities, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ARE

11/27/2025 09:00 AM • Rosen Law Firm filed a class action lawsuit against Alexandria Real Estate Equities for allegedly providing misleading statements about revenue, operations, and property leasing value during January-October 2025.

ARE - Lawsuit alleges the company disseminated false and misleading statements about revenue growth, lease activity, and property value, potentially causing investor damages

#securities lawsuit #class action #real estate #investor rights

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP

GlobeNewswire Inc. • Rosen Law Firm

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP

11/27/2025 09:00 AM • Rosen Law Firm is pursuing a securities class action lawsuit against Inspire Medical Systems for allegedly misrepresenting market demand and launch details of their Inspire V sleep apnea device during the period of August 6, 2024 to August 4, 2025.

INSP - The lawsuit alleges the company misrepresented key facts about their Inspire V device, potentially misleading investors about market demand and launch readiness, which suggests potential corporate misconduct

#securities class action #sleep apnea device #investor lawsuit

Legend Biotech Awarded 2025 FIBA Foreign Investor of the Year by Flanders Investment & Trade

GlobeNewswire Inc. • Legend Biotech Corporation

Legend Biotech Awarded 2025 FIBA Foreign Investor of the Year by Flanders Investment & Trade

11/27/2025 09:00 AM • Legend Biotech was awarded Foreign Investor of the Year at the 2025 Flanders International Business Awards for its €165 million investment with Johnson & Johnson to expand cell therapy manufacturing in Ghent, Belgium, growing from 2 to over 1,000 employees.

LEGN - Received prestigious business award, significant investment, rapid workforce expansion, and recognition for contributing to regional biotech ecosystem

#cell therapy #biotech #investment #manufacturing #CAR-T

Antitumor ADC Drugs Market Forecast Shows Strong 12.86% CAGR Through 2035

GlobeNewswire Inc. • Towards Healthcare

Antitumor ADC Drugs Market Forecast Shows Strong 12.86% CAGR Through 2035

11/27/2025 09:00 AM • The global antitumor antibody-drug conjugate (ADC) drugs market is projected to grow from $8.33 billion in 2026 to $24.75 billion by 2035, driven by precision cancer therapies with reduced systemic toxicity and increasing cancer diagnoses worldwide.

RHHBY - Continues expanding ADC portfolio with multiple ongoing clinical trials targeting various cancer types

#ADC drugs #oncology #cancer treatment #precision therapeutics #antibody-drug conjugates

These 2 Energy Titans Just Scored Major Wins to Close Out November

Investing.com • Leo Miller

These 2 Energy Titans Just Scored Major Wins to Close Out November

11/27/2025 08:52 AM • Two energy companies, Constellation Energy and GE Vernova, saw significant stock gains in November due to strategic developments in nuclear and natural gas energy sectors, including government support and promising business agreements.

CEG - Received $1 billion Department of Energy loan to restart Three Mile Island reactor, signed 20-year deal with Microsoft, delivered 58% total stock return in 2025, and demonstrated strong government support for nuclear energy

#nuclear energy #AI energy demand #natural gas turbines #clean energy

DXCM DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

GlobeNewswire Inc. • Rosen Law Firm

DXCM DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

11/27/2025 08:00 AM • Rosen Law Firm alerts DexCom investors about a securities class action lawsuit alleging unauthorized design changes to glucose monitoring systems that potentially compromised device reliability and user health risks.

DXCM - Lawsuit alleges the company made unauthorized design changes to medical devices, potentially compromising user safety, reliability, and facing potential regulatory scrutiny and legal/financial harm

#securities #class action #FDA #glucose monitoring #investor rights